Vanguard Group’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.4M Buy
3,365,547
+905,097
+37% +$4.41M ﹤0.01% 2646
2025
Q1
$9.1M Buy
2,460,450
+1,059,192
+76% +$3.92M ﹤0.01% 2899
2024
Q4
$5.61M Buy
1,401,258
+30,207
+2% +$121K ﹤0.01% 3229
2024
Q3
$9.56M Buy
1,371,051
+12,668
+0.9% +$88.3K ﹤0.01% 2975
2024
Q2
$7.7M Buy
1,358,383
+113,808
+9% +$645K ﹤0.01% 3057
2024
Q1
$16.6M Buy
1,244,575
+920,404
+284% +$12.3M ﹤0.01% 2692
2023
Q4
$1.99M Buy
324,171
+74,111
+30% +$455K ﹤0.01% 3607
2023
Q3
$630K Buy
250,060
+2,018
+0.8% +$5.09K ﹤0.01% 3988
2023
Q2
$1.3M Buy
248,042
+25,345
+11% +$133K ﹤0.01% 3819
2023
Q1
$1.06M Hold
222,697
﹤0.01% 3896
2022
Q4
$1.2M Buy
222,697
+87
+0% +$468 ﹤0.01% 3851
2022
Q3
$1.56M Buy
222,610
+49,874
+29% +$349K ﹤0.01% 3849
2022
Q2
$1.6M Buy
172,736
+31,723
+22% +$293K ﹤0.01% 3903
2022
Q1
$2.54M Sell
141,013
-30,877
-18% -$556K ﹤0.01% 3865
2021
Q4
$4.51M Sell
171,890
-14,016
-8% -$368K ﹤0.01% 3665
2021
Q3
$6.67M Buy
185,906
+1,721
+0.9% +$61.7K ﹤0.01% 3482
2021
Q2
$10.1M Sell
184,185
-4,870
-3% -$267K ﹤0.01% 3189
2021
Q1
$15.7M Buy
189,055
+76,997
+69% +$6.39M ﹤0.01% 2919
2020
Q4
$12.7M Buy
112,058
+59,478
+113% +$6.76M ﹤0.01% 2865
2020
Q3
$1.6M Sell
52,580
-3,262
-6% -$99.4K ﹤0.01% 3548
2020
Q2
$2.46M Sell
55,842
-1,813
-3% -$79.7K ﹤0.01% 3374
2020
Q1
$2.07M Buy
57,655
+168
+0.3% +$6.02K ﹤0.01% 3305
2019
Q4
$3.84M Buy
57,487
+680
+1% +$45.4K ﹤0.01% 3257
2019
Q3
$8.81M Buy
56,807
+1,452
+3% +$225K ﹤0.01% 2884
2019
Q2
$4.77M Buy
55,355
+5,801
+12% +$500K ﹤0.01% 3185
2019
Q1
$6.84M Buy
49,554
+16,092
+48% +$2.22M ﹤0.01% 3011
2018
Q4
$13.5M Sell
33,462
-11,550
-26% -$4.64M ﹤0.01% 2624
2018
Q3
$31.9M Buy
45,012
+20,286
+82% +$14.4M ﹤0.01% 2356
2018
Q2
$13.2M Buy
24,726
+689
+3% +$368K ﹤0.01% 2762
2018
Q1
$2.71M Buy
+24,037
New +$2.71M ﹤0.01% 3354